Kalaris Therapeutics KLRS
NASDAQ KLRS
$1.90 +0.03 (+1.60%)
At close: Nov 11, 2026 · 4:00 PM EST

Kalaris Therapeutics (KLRS) Total Debt (2019 - 2026)

Updated

Kalaris Therapeutics (KLRS) reported Total Debt of $19.54 million for Q4 2024.

Analysis

Kalaris Therapeutics (KLRS) Total Debt (2019 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 49.50 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 44.65 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 80.90 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 53.78 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -6.68 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 54.01 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 26.23 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 62.67 Bn
10 Kalaris Therapeutics 44.52 Mn -38.38 Mn - -499,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -499,000.00
Jun 30, 2026 -543,000.00
Dec 31, 2024 19.54 Mn
Jun 30, 2024 667,000.00
Mar 31, 2024 2.30 Mn
Dec 31, 2023 10.78 Mn
Sep 30, 2023 12.98 Mn
Jun 30, 2023 8.48 Mn
Mar 31, 2023 8.27 Mn
Dec 31, 2022 7.17 Mn
Sep 30, 2022 1.92 Mn
Jun 30, 2022 2.24 Mn
Mar 31, 2022 2.36 Mn
Dec 31, 2021 6.59 Mn
Sep 30, 2021 6.30 Mn
Jun 30, 2021 4.83 Mn
Mar 31, 2021 4.79 Mn
Dec 31, 2020 3.23 Mn
Sep 30, 2020 3.19 Mn
Jun 30, 2020 3.15 Mn
API Access

Kalaris Therapeutics Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=KLRS&period=max&api_key=YOUR_API_KEY